Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

60
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

366
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
366
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

200
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
200
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

237
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
237
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

350
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
350
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

329
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply.

Journal of vascular surgery·2026
Same author

What Lies Beneath: Carotid Artery Depth and the Safe Use of Hemostatic Nets in Facelift Surgery.

Aesthetic surgery journal·2026
Same author

Corrigendum to: Historically, did Cemented Thompson perform better than uncemented Austin Moore hemiarthroplasty for femoral neck fractures? A meta-analysis of available evidence.

SICOT-J·2026
Same author

An uncommon complication of coil embolization: Coil deployment system malfunction leading to retained intra-aortic wire.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Association of GLP-1 Receptor Agonist Use with Hypersomnolence: A Real-world Cohort Analysis.

Journal of diabetes and metabolic disorders·2026
Same author

National Trends, Gender, Racial, and Regional Disparities in Pulmonary Embolism Mortality Before and After the COVID-19 Pandemic in the United States: Analysis from the CDC-Wonder Database, 2018-2023.

Annals of vascular surgery·2026
Same journal

Expecting the Unexpected.

The Nursing clinics of North America·2026
Same journal

Nursing at the Center of Emergencies.

The Nursing clinics of North America·2026
Same journal

A Scoping Review on Managing Mental Health Emergencies in Elderly Population in WHO Regions.

The Nursing clinics of North America·2026
Same journal

Support Strategies and Policy Recommendations to Manage the Aftermath of an Emergency or Traumatic Situation.

The Nursing clinics of North America·2026
Same journal

Navigating Extreme Weather Events: Experiences of Nursing Leaders in a Rural, Acute Care Hospital in Atlantic Canada.

The Nursing clinics of North America·2026
Same journal

Ensuring Patient-Centered Care During an Emergency in Resource-Constrained Primary Health Care Settings.

The Nursing clinics of North America·2026
See all related articles

Related Experiment Video

Updated: May 30, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

208

Updates in Arterial Ulcers.

Karen L Bauer1, Ahmed M Afifi1, Munier Nazzal2

  • 1Division of Vascular, Endovascular and Wound Surgery, University of Toledo, Mail Stop 1095, 3000 Arlington Avenue, Toledo, OH 43614-2598, USA.

The Nursing Clinics of North America
|January 30, 2025
PubMed
Summary
This summary is machine-generated.

Arterial ulcers, often indicating peripheral artery disease (PAD), require re-establishing blood flow through revascularization. Medical and topical therapies are crucial for healing and preventing infection.

Keywords:
Arterial ulcerCritical limb threatening ischemiaIschemic ulcerNonhealing ulcerPeripheral artery disease

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

2.8K

Related Experiment Videos

Last Updated: May 30, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

208
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.4K
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

2.8K

Area of Science:

  • Vascular Surgery
  • Dermatology
  • Podiatry

Background:

  • Arterial ulcers are manifestations of underlying peripheral artery disease (PAD).
  • Chronic limb-threatening ischemia signifies end-stage PAD.
  • Other ulcer etiologies may involve arterial compromise, necessitating thorough evaluation.

Purpose of the Study:

  • To highlight the significance of PAD in arterial ulcer formation.
  • To emphasize the diagnostic approach for lower extremity ulcers.
  • To outline current therapeutic strategies for arterial ulcers.

Main Methods:

  • Comprehensive patient history and physical examination.
  • Risk factor identification for PAD.
  • Diagnostic testing for lower extremity vascular assessment.
  • Review of endovascular and open revascularization techniques.
  • Evaluation of medical and topical treatment modalities.

Main Results:

  • Re-establishing in-line arterial flow is the primary treatment goal.
  • Endovascular therapy and open revascularization are key revascularization methods.
  • Medical management slows PAD progression.
  • Topical therapies aid ulcer closure and infection prevention.

Conclusions:

  • Prompt recognition and diagnosis of arterial ulcers are critical.
  • Revascularization is essential for treating the underlying PAD.
  • Multimodal treatment, including medical and topical care, optimizes outcomes for arterial ulcers.